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Abstract
Purpose:  Neurocysticercosis  (NCC)  is  considered  to  be  rare  in  Kerala  state,  India,
although  it  is  an  important  cause  of  epilepsy  in  many  other  parts  of  India.  Our
objective  was  to  test  this  notion  by  determining  the  seroprevalence  of  cysticercosis
(CC)  in  an  unselected  sample  of  persons  with  epilepsy  and  comparing  it  to  that  of
persons  without  epilepsy  living  in  Kerala.
Methods:  Individuals  with  active  epilepsy  (AE)  who  had  never  resided  outside  Ker-
ala  state  for  more  than  one  month  and  were  attending  our  center  for  epilepsy  care
constituted  the  cases.  Sex-matched  persons  without  epilepsy  who  had  never  resided
outside  Kerala  state  for  more  than  one  month  constituted  the  controls.  The  demo-
graphic  details,  occupation,  and  food  habits  (for  the  cases  and  controls),  as  well  as
clinical  characteristics  and  imaging  (for  cases  only)  were  recorded.  Sera  separated
from  blood  drawn  by  venipuncture  from  the  cases  and  controls  were  assayed  for
cysticercal  antibodies  by  enzyme-linked  immunoelectrotransfer  blot  (EITB).
Results:  Of  the  80  persons  with  AE,  12  were  seropositive  for  cysticercus  antibodies
(15%;  95%  CI:  8.8—24.4);  among  the  68  controls,  7  were  seropositive  (10.3%;  95%  CI:
5.1—19.8).  The  odds  ratio  (OR)  for  seropositivity  in  the  epilepsy  group  (1.54)  was  not
statistically  signiﬁcant  (95%  CI:  0.6—4.2).  Among  the  69  patients  who  had  a  brain
computed  tomography  (CT)  scan  or  magnetic  resonance  imaging  (MRI),  none  had
∗ Corresponding author at: Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum
95011, India. Tel.: +91 471 2524468; fax: +91 471 2443255.
E-mail addresses: sanjeev.v.thomas@gmail.com, sanjeev@sctimst.ac.in (S.V. Thomas).
876-0341/$ — see front matter © 2014 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.
ttp://dx.doi.org/10.1016/j.jiph.2013.08.005
272  A. Cherian  et  al.
features  diagnostic  of  NCC.  Gender,  diet  (vegetarian  vs  non-vegetarian,  consump-
tion  of  raw  vegetables),  drinking  water  status  (clean  vs  unclean),  residence  (rural
vs  urban),  exposure  to  manure,  and  animal  rearing  including  pigs  did  not  have  any
itivity.
esidents  of  Kerala,  most  epilepsy  is  not  related  to  cysticer-
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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approved  by  the  Institutional  Ethics  Committee  and
informed consent  was  obtained  from  every  subjectassociation  with  seropos
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Introduction
Neurocysticercosis  (NCC)  is  caused  by  the  larval
stage  of  the  tapeworm  Taenia  solium  in  the  nervous
system. It is  the  single  most  common  (26.3—53.8%)
cause of  acquired  epileptic  seizures  in  India  and
other  developing  countries  [1,2].  NCC  is  now  an
emerging  health  problem  in  industrialized  countries
due to  increased  population  movement  and  migra-
tion [3].  Although  NCC  presents  as  seizures  in
nearly 70%  of  patients  [4], there  are  only  a few
case—control studies  on  the  prevalence  of  NCC
among patients  with  active  epilepsy  (AE).  The
prevalence  of  NCC  in  different  studies  available  in
India and  other  countries  vary  widely  according  to
the methodology.  The  socioeconomic  and  cultural-
religious  backgrounds  of  the  population  are  likely
to inﬂuence  the  prevalence  of  NCC.  It  is  generally
considered that  NCC  is  uncommon  in  the  state  of
Kerala, where  educational  and  health  standards  are
high, and  in  Kashmir,  where  people  do  not  rear  pigs
or eat  pork  due  to  religious  customs  [5,6].
There are  limitations  in  establishing  NCC  as  the
cause of  epilepsy  in  community  studies.  Brain  imag-
ing by  computed  tomography  (CT)  scan  or  magnetic
resonance imaging  (MRI)  is  most  likely  the  best
method to  diagnose  NCC  but  may  not  be  feasible  in
community  studies  because  of  their  high  cost  and
limited  availability.  Seroprevalence  for  cysticerco-
sis can  be  estimated  by  ELISA  or  enzyme-linked
immunoelectrotransfer  blot  (EITB)  techniques.  The
estimation  of  antibodies  by  EITB  has  higher  sen-
sitivity  than  ELISA  (92.2  vs  51.6%)  when  serum
is sampled  [7].  Most  studies  in  India  and  other
countries indicate  increased  seroprevalence  among
persons  with  epilepsy  [1]. We  tested  the  hypothe-
sis that  there  is no  increase  in  the  seroprevalence
of cysticercus  antibodies  in  persons  with  epilepsy
compared to  those  without  epilepsy  in  Kerala  state.
We estimated  the  seroprevalence  of  cysticercal
antibodies by  EITB  in  an  unselected  sample  of  per-
sons with  AE  attending  a  tertiary  hospital  in  Kerala
State and  compared  it  with  the  value  for  sex-
matched persons  without  epilepsy.
i
t
daterials and methods
his  study  was  carried  out  in  Sree  Chitra  Tirunal
nstitute for  Medical  Sciences  and  Technology
SCTIMST), Trivandrum,  Kerala,  a  tertiary  referral
enter  for  epilepsy  and  other  neurological  dis-
rders. The  samples  were  analyzed  at  Christian
edical College  (CMC),  which  is  also  a  tertiary
eferral center  at  Vellore,  Tamil  Nadu.  The  study
as conducted  between  January  2010  and  October
011.
The  selection  criteria  for  the  epilepsy  group
ere persons  with  active  epilepsy  and  18—60
ears old.  Epilepsy  was  deﬁned  as  an  enduring
redisposition to  generate  seizures  due  to  recur-
ent and  unpredictable  interruptions  of  normal
rain function  [8]. The  diagnosis  of  epilepsy  was
onﬁrmed  by  history,  while  the  etiology  was  deter-
ined by  clinical  examination  and  data  from  EEG,
T, or  MRI  abstracted  from  the  patients’  medi-
al records.  Active  epilepsy  was  deﬁned  as  two
r more  seizures  in  the  past  ﬁve  years  or  a  his-
ory of  recurrent  seizures  and  currently  being
eizure free  while  using  antiepileptic  drugs  [9].
ll had  at  least  one  year  duration  of  epilepsy
rior to  enrolment.  The  comparator  group  included
ex- and  age-matched  persons  without  epilepsy.
oth groups  should  have  lived  continuously  in  Ker-
la state  and  not  traveled  outside  the  state  for
ore than  one  month  in  their  lifetime.  Migrant
opulations were  excluded.  Controls  were  iden-
iﬁed from  the  families  of  epilepsy  patients.
ontrols were  also  evaluated  by  history  and  exam-
nation.  A  standard  questionnaire  in  the  local
anguage (Malayalam)  regarding  food  habits  (con-
umption  of  salads  and  uncooked  vegetables  and
eat, particularly  pork),  agricultural  activities,
nd pig/cattle/pet  rearing  was  administered  to
ll patients  and  controls.  The  study  protocol  wasn the  local  language.  The  investigators  analyzing
he serum  samples  were  blinded  to  the  clinical
etails.
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Five  milliliters  of  venous  blood  was  drawn  from
ases and  controls;  the  serum  was  separated  and
tored  at  −70 ◦C  until  assay.  Blinding  the  con-
ainers was  performed  by  labeling  with  dummy
umbers after  masking  the  identity  by  standard
oding methods,  and  the  codes  were  only  avail-
ble  from  the  principal  investigator.  Sera  were
ransferred  frozen  to  the  Neurochemistry  Labo-
atory,  Department  of  Neurological  Sciences  at
hristian  Medical  College,  Vellore,  for  assay  of
ysticercus  antibodies  by  EITB,  as  described  in  a
revious study  [10].  Brieﬂy,  lentil  lectin-speciﬁc  T.
olium metacestode  glycoproteins  (250  ng/mm  gel)
ubjected  to  non-reducing  sodium  dodecyl  sulfate
olyacrylamide  gel  electrophoresis  (4—20%  gels)
ere electro-transferred  onto  polyvinylidene  ﬂuo-
ide membranes.  The  blots  were  blocked  with  5%
at-free casein  in  phosphate-buffered  saline,  incu-
ated with  100×  diluted  sera,  and  then  incubated
ith goat  anti-human  immunoglobulin  G  and  rabbit
nti-goat  immunoglobulin  G-horseradish  peroxi-
ase and  developed  with  H2O2/diaminobenzidine.
he blots  were  analyzed  independently  by  two
aboratory personnel,  and  sera  were  considered
ositive for  cysticercus  antibodies  on  reaction  with
ne or  more  T.  solium  glycoproteins  of  molecular
eights 50,  38—42,  24,  21,  18,  14,  and  13  kDa  [11].
tatistical analysis
ata  entry  and  analysis  were  completed  using  the
PSS 17  (Chicago,  IL)  statistical  package.  Crude
dds ratios  were  calculated  to  estimate  the  rela-
ive risk.  The  distribution  of  independent  variables
mong case  and  control  groups  was  analyzed  by  the
earson Chi-Square,  Fisher  Exact  Test,  and  t-test.
ifferences  were  considered  statistically  signiﬁcant
t P  <  0.05.
esults
 total  of  80  persons  (50  females  and  30  males)  with
E were  enrolled  in  the  study.  Their  seizures  were
lassiﬁed  as  generalized  for  25  (31.2%)  and  partial
or 55  (68.8%).  All  had  at  least  one  year  of  epilepsy
rior to  enrolment,  and  none  were  treatment  naive.
T scan  or  MRI  of  the  brain  was  available  for  69  out
f 80  patients  (86.2%),  of  which  23  (33.3%)  were
bnormal (mesial  temporal  sclerosis  8,  atrophy  2,
uberculoma  3,  arachnoid  cyst  4,  gliosis  2,  caver-
oma  1,  infarct  2,  cortical  malformation  1).  None  of
he patients  with  epilepsy  had  lesions  suggestive  of
CC. The  control  group  had  68  persons  (41  females
nd 27  males).  There  was  no  signiﬁcant  difference
n
w
a
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etween  the  cases  and  controls  with  regard  to
ural domicile  (73%  vs  74%),  access  to  clean  drink-
ng water  (94%  vs  98%),  exposure  to  manure  (27%
s 25%),  uncooked  vegetable  consumption  (89%  vs
4%), and  non-vegetarian  food  consumption  (90  vs
3%). The  mean  age  in  years  of  the  control  group
39.2  ±  14.6)  was  higher  than  (p  = 0.01)  that  of  the
atients (33.6  ±  10.2).  Animal  handling/rearing  was
igniﬁcantly  higher  (p  = 0.001)  among  the  controls
85%) than  among  the  patients  (37%).  Although  the
ontrol group  differed  from  the  cases  with  respect
o age  and  exposure  to  animals,  the  differences
ere not  likely  to  inﬂuence  the  hypothesis.
erologic results
ITB  was  positive  for  12  of  the  80  cases  (15%,  95%  CI:
.8—24.4) and  7  of  the  68  controls  (10.3%;  95%  CI:
.1—19.8).  Among  the  12  positive  patients,  8  had  a
ingle band,  one  had  two  bands,  3  had  three  bands,
nd none  had  four  bands.  Among  the  7  positive  con-
rols, 2  had  a single  band,  2 had  two  bands,  2  had
hree bands,  and  one  had  four  bands.  The  odds  ratio
or seropositivity  for  the  epilepsy  cases  (1.5,  95%  CI
57—4.2) was  not  statistically  signiﬁcant.  Within  the
pilepsy group,  there  was  no  statistically  signiﬁcant
ifference in  the  seropositivity  for  the  variables:
ender (male  vs  female),  residence  (rural  vs  urban),
iet (vegetarian  vs  non-vegetarian),  consumption
f raw  vegetables,  access  to  drinking  water  (clean
s unclean  source),  and  animal  rearing  including
igs (Table  1). There  was  no  association  between
eropositivity and  the  type  of  seizure  (generalized
s partial).
iscussion
he  key  observation  in  this  study  is  that  the  preva-
ence of  cysticercal  antibodies  in  an  unselected
ample of  individuals  with  epilepsy  living  in  Ker-
la was  not  signiﬁcantly  different  from  that  of
ersons without  epilepsy  living  in  the  same  geo-
raphic  region.  There  was  no  difference  in  the
eroprevalence  according  to  gender,  habitat,  or
ccupation.  Furthermore,  none  of  the  69  individ-
als with  epilepsy  for  whom  imaging  data  were
vailable  had  evidence  of  NCC.
Based on  the  seroprevalence  and  negative
ndings on  imaging,  we  conclude  that  neurocys-
icercosis is  not  an  important  cause  of  epilepsy  in
ative Keralites.  Prevalence  of  cysticercosis  varies
idely depending  upon  the  methods  of  diagnosis
nd the  geographic  location  (Table  2).  In  gen-
ral, studies  utilizing  CT  or  MRI  have  the  highest
274  A. Cherian  et  al.
Table  1  Demographics,personal  data  and  seroprevalence  of  cysticercal  antibodies  in  people  with  epilepsy  and
controls.
Controls  Patients  p  Value
Number  68  80
Mean  age  (years) 39  34  .01
Non  vegetarians  (%) 93 90  .77
Access  to  clean  water  (%) 98  94  .22
Rural  population  (%)  74  73  1.0
Uncooked  vegetable  consumption  (%)  94  89  .77
Exposure  to  manure  (%)  25  27  .85
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4Exposure  to  pig  rearing  (%)  
Seroprevalence  of  cysticercal  antibodies  (%)  
positivity,  followed  by  detection  of  cysticercal  anti-
bodies in  the  serum  using  EITB  and  ELISA  techniques
[1,22,26].
Earlier  studies  utilizing  clinical  evaluation  or
imaging  had  failed  to  detect  NCC  as  a  cause
of epilepsy  in  Kerala  [5,12]. This  is  the  ﬁrst
case—control study  using  serological  techniques
that conﬁrms  that  cysticercosis  is  not  a  common
cause of  epilepsy  in  Kerala  state,  unlike  Tamil  Nadu
or Andhra  Pradesh,  locations  where  it  accounts  for
38—45% of  epilepsy  [1,13].  The  seroprevalence  of
cysticercus  in  this  study  (10%  in  the  comparator
group and  15%  in  the  epilepsy  group)  is  not  different
from  the  seroprevalence  in  the  population  of  Tamil
Nadu  (13%)  [1]  or  Chandigarh  (17.3%)  [17],  where
approximately  one-third  of  epilepsy  is  attributed  to
NCC. One  possibility  for  the  low  levels  of  the  dis-
ease,  in  spite  of  the  comparable  seroprevalence,
could be  that  the  immune  response  had  prevented
its further  evolution  to  NCC.  EITB  has  a  low  speci-
ﬁcity  compared  to  imaging  modalities  with  regard
to the  ascertainment  of  NCC.  Our  results  also  sup-
port this  ﬁnding,  as  15%  of  our  epilepsy  cases  were
EITB positive,  but  none  had  imaging  evidence  of
NCC.
t
T
T
Table  2  Burden  of  cysticercosis  in  various  Indian  states.
Place  Type  of  study  Sam
Kerala  (present  study)  Hospital Epi
Con
Vellore  2006  (India)  [1]  Population  Epi
Chandigarh  2006  (India)  [17]  Population  Uns
Lucknow  2010  (India)  [18]  Population  Uns
Pondicherry  2005  (India)  [19] Blood  donors  Uns
New  Delhi  1994  (India)  [20] Hospital  Epi
CT = computed tomography; EITB = enzyme linked immunoelectro
MRI = magnetic resonance imaging; NCC* = neurocysticercosis as per4  0  .09
10.3  15  .47
The  relative  rarity  of cysticercosis  as  a cause
f epilepsy  in  Kerala  state  is  of  public  health
mportance. The  people  of  Kerala  share  ethnic-
ty, socio-economic,  and  religious  backgrounds  with
hose living  in  other  south  Indian  states.  A  good
roportion of  the  vegetables,  food  grains,  and
eat products  consumed  here  are  brought  in  from
he neighboring  states  where  there  is  a higher
revalence of  NCC  (Table  2).  With  these  shared
haracteristics,  one  would  expect  the  prevalence
f NCC  in  Kerala  state  to  be  similar  to  that  in  the
eighboring  states.  In  contrast  to  these  shared  char-
cteristics,  Kerala  has  a higher  literacy  rate  (93.2%)
nd better  health-related  vital  statistics  [14,15].
he chain  of  infection  in  taeniasis  involves  the
ntermediate  host,  the  pig,  while  that  of  NCC  does
ot involve  pigs  and  is  essentially  due  to  fecal-oral
ontamination. According  to  the  National  Family
ealth  Survey  III,  (2005—6)  96%  of  households  in
erala have  proper  toilet  facilities,  while  in  the
djoining  states  of  Tamil  Nadu  and  Karnataka,  only
3% and  46%  of  households  have  this  facility,  respec-
ively  [16]. This  possibly  leaves  little  chance  for
aenia ova  to  be  ingested  through  food  in  Kerala.
he higher  standards  of  sanitation  especially  the
ple  Technique  %
lepsy  EITB
CT/MRI
15
0
trols  EITB  10.3
lepsy  EITB
CT
NCC*
13
28.4
34
elected  EITB  17.3
elected  ELISA  3.4
elected  ELISA  6.48
lepsy  MRI  24
transfer blot; ELISA = enzyme-linked immunosorbent assay;
 criteria laid down by Del Brutto et al. [28].
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Table  3  Comparison  of  burden  of  cysticercosis  with  data  from  other  countries.
Place  Type  of  study  Sample  Technique  %
Kerala,  India
(present  study)
Hospital Epilepsy  EITB/CT  or  MRI  15/0
Controls  EITB  10.3
Ecuador  2005  [21]  Population Epilepsy  EITB/CT/NCC*  33/26.3/33
Control  EITB/CT  8.3/5.2
Bolivia  2005  [22] Population  Epilepsy  EITB/CT/NCC*  18.6/29.5/27.4
Peru  2003  [23] Population Unselected  EITB  14
Brazil  2002  [24] Population Unselected  EITB  1.6
Indonesia  1999  [25] Population Unselected  ELISA  1.65
Columbia  1998  [26]  Hospital  Epilepsy  EITB/CT  12/13
Korea1993  [27] Population  Epilepsy  ELISA  4
Control  ELISA  2.1
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[CT = computed tomography; EITB = enzyme linked immunoel
MRI = magnetic resonance imaging; NCC* = Neurocysticercosis a
vailability  of  protected  toilets  reduce  the  risk  of
va contaminating  the  food  or  water  sources.  Sal-
ds, uncooked  vegetables,  and  uncooked  dishes  are
ot part  of  Kerala  cuisine.  Traditionally,  the  people
n Kerala  consume  all  food  items,  including  drink-
ng water,  after  cooking  or  boiling,  which  further
educes the  survival  of  live  parasites.  Lastly,  the
urden of  stray  pigs  is  very  low  in  Kerala,  which
n turn  limits  the  taeniasis  cycle.  It  appears  that
he rarity  of  epilepsy  associated  with  cysticercosis
n Kerala  state  is multifactorial  and  dependent  on
he sociocultural  characteristics,  food  habits,  and
mmune status  of  the  people.  Further  studies  in  this
eld could  potentially  lead  to  methods  to  contain
CC in  different  parts  of  the  world  (Table  3).
onclusion
mong  the  residents  of  Kerala,  most  epilepsy  is  not
elated to  cysticercosis,  unlike  in  other  states  of
ndia.
unding
o  funding  sources.
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